awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38198582-288124AC-A5D6-45BB-85C6-6D8B6EFEEAF8
Q38198582-288124AC-A5D6-45BB-85C6-6D8B6EFEEAF8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38198582-288124AC-A5D6-45BB-85C6-6D8B6EFEEAF8
Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.
P2860
Q38198582-288124AC-A5D6-45BB-85C6-6D8B6EFEEAF8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38198582-288124AC-A5D6-45BB-85C6-6D8B6EFEEAF8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b6f83adaf33315195c17783e665d6a2b918055b6
P2860
Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer